1. Developing Country Vaccine Markets
Presentation to 2015 DCVMN Meeting
Amie Batson
Chief Strategy Officer, PATH
October 2015
PATH/Eric Becker

2. Agenda What is the “developing country” vaccine market?
Globally financed developing country vaccine market –
Demand
Supply
Financing
Opportunities and challenges for the future 2

3. Changing Demand Landscape - 2006
Source: UNICEF public data 3

4. Changing Demand Landscape - 2007
Source: UNICEF public data 4

5. Changing Demand Landscape - 2008
Source: UNICEF public data 5

6. Changing Demand Landscape - 2009
Source: UNICEF public data 6

7. Changing Demand Landscape - 2010
Source: UNICEF public data 7

8. Changing Demand Landscape - 2011
Rapid adoption of PCV
Source: UNICEF public data 8

9. Changing Demand Landscape - 2012
Source: UNICEF public data 9

10. Changing Demand Landscape - 2013
Source: UNICEF public data 10

11. Changing Demand Landscape - 2014
Source: UNICEF public data 11

12. New Product Combinations – DTP Family 1998-2014
Source: UNICEF public data 12

13. New Product Combinations – Measles Family 2014-2030
Source: PATH Global Vaccines Market Model. Provided for illustrative purposes only 13

14. Increasing Value (UNICEF Contracts 2001-14)
Source: UNICEF public data 14

15. New Markets (Gavi Graduation 2015-30)
Source: PATH Global Vaccines Market Model. Provided for illustrative purposes only. 15

16. New Markets (Gavi Graduation 2015-30)
Source: PATH Global Vaccines Market Model. Provided for illustrative purposes only. 16

17. New Markets (Gavi Graduation 2015-30)
Source: PATH Global Vaccines Market Model. Provided for illustrative purposes only. 17

18. New Markets (Gavi Graduation 2015-30)
Source: PATH Global Vaccines Market Model. Provided for illustrative purposes only. 18

19. New Products in the Pipeline
Source: WHO public data; PATH and partners’ analysis, July 2015 19

20. Examples of Manufacturers Leading the Way
Chengdu Institute of Biological Products (CDIBP) Japanese encephalitis
Serum Institute of India Ltd. Meningitis A 20

21. DCVM diversity Market Driver Product Portfolio/ Production Scale
Emerging MNCs
New
Entrants
Parastatal
Global Actors
Local Gatekeepers
Niche
Largest
Product Portfolio/
Production Scale
Privately Held
State-owned
Market Driver

22. DCVM diversity Market Driver Product Portfolio/ Production Scale
Parastatal
Global Actors
Local Providers
State-owned
Market Driver
Emerging MNCs
New
Entrants
Privately Held
Niche
Largest
Product Portfolio/
Production Scale

23. DCVM diversity Product Portfolio/ Production Scale Local Providers New
Parastatal
Global Actors
Local Providers
Emerging MNCs
New
Entrants
State-owned
Privately Held
Niche
Largest
Market Driver
Product Portfolio/
Production Scale
Not exhaustive

24. Opportunities and Challenges for the Future
Regulatory Approval/PQ
GAVI Graduation
Access to high margin markets
Shift to combination vaccine
Advantage for Regional Products?
Market Knowledge
Lower Cost
Creative partnership

25. twitter.com/PATHtweets twitter.com/AmieBatson
Connect with Me
twitter.com/PATHtweets twitter.com/AmieBatson 25